☆ 4.6 Review

Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel

DRUG SAFETY (2023)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

Efficacy of the granisetron transdermal system for the control of nausea and vomiting induced by highly emetogenic chemotherapy: a multicenter, randomized, controlled trial

Der Sheng Sun et al.

Summary: This study compared the efficacy of the granisetron transdermal system (GTS) with ondansetron for controlling chemotherapy-induced nausea and vomiting. The results showed that GTS was not inferior to ondansetron in controlling CINV, and it also improved the quality of life in patients.

KOREAN JOURNAL OF INTERNAL MEDICINE (2023)

Add to Collection

Article Medicine, General & Internal

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

Sara A. Hurvitz et al.

Summary: In the DESTINY-Breast03 trial, trastuzumab deruxtecan showed superior progression-free survival compared to trastuzumab emtansine in patients with HER2-positive metastatic breast cancer. The study aimed to compare the efficacy and safety of trastuzumab deruxtecan versus trastuzumab emtansine. The results demonstrated that trastuzumab deruxtecan had the longest reported median progression-free survival and improved overall survival, reaffirming its role as the standard of care in the second-line setting.

LANCET (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

ESC 2022 guidelines on cardio-oncology in collaboration with the European Hematology Association (EHA), European Society of Therapeutic Radiology and Oncology (ESTRO) and International Cardio-Oncology Society (IC- OS) developed by the Cardio-Oncology Task Force of the European Society of Cardiology (ESC)

Alexander R. Lyon et al.

GIORNALE ITALIANO DI CARDIOLOGIA (2023)

Add to Collection

Article Medicine, General & Internal

The impact of race and ethnicity in breast cancer-disparities and implications for precision oncology

Kelly A. Hirko et al.

Summary: Breast cancer, as one of the leading causes of cancer death globally, displays variations in incidence, pathological features, and clinical outcomes across geographical and racial/ethnic populations. However, there is a lack of racial and ethnic diversity in breast cancer clinical trials, with underrepresentation of both Blacks and Hispanics. In this forum article, breast cancer researchers discuss the factors contributing to racial and ethnic disparities in breast cancer and emphasize the specific implications of precision oncology approaches in achieving equitable provision of care and addressing disparities.

BMC MEDICINE (2022)

Add to Collection

Article Virology

Prolonged corticosteroid therapy and cytomegalovirus infection in patients with severe COVID-19

Yuji Yamamoto et al.

Summary: In patients with severe COVID-19 treated with systemic corticosteroid therapy, monitoring cytomegalovirus (CMV) infection is important for preventing secondary infections. The presence of CMV infection is associated with increased risk of mortality during the ICU stay.

JOURNAL OF MEDICAL VIROLOGY (2022)

Add to Collection

Article Primary Health Care

The 1-minute sit-to-stand test to detect desaturation during 6-minute walk test in interstitial lung disease

Keiji Oishi et al.

Summary: This study evaluated the usefulness of the 1 min sit-to-stand test (1STST) for assessing desaturation during the 6 min walk test (6MWT) in patients with interstitial lung disease (ILD). The results showed a strong correlation between the 1STST and 6MWT in measuring the lowest oxygen saturation levels, and the frequency of patients with oxygen saturation < 90% was consistent for both tests. Furthermore, the 1STST was found to be superior to diffusing capacity for carbon monoxide in detecting desaturation during the 6MWT. Therefore, the 1STST can be an alternative method for measuring exertional desaturation in ILD patients with normal resting blood oxygen levels.

NPJ PRIMARY CARE RESPIRATORY MEDICINE (2022)

Add to Collection

Review Oncology

Emetogenicity of Antibody-Drug Conjugates (ADCs) in Solid Tumors with a Focus on Trastuzumab Deruxtecan: Insights from an Italian Expert Panel

Giampaolo Bianchini et al.

Summary: This study discusses the effectiveness and side effects of antibody-drug conjugates (ADCs) in the treatment of solid tumors, with nausea and vomiting being the most common adverse reactions. The expert panels propose methods and recommendations for preventing and mitigating ADC-associated emesis, but further research and evidence are needed.

CANCERS (2022)

Add to Collection

Review Dermatology

Psychological Aspects of Hair Disorders: Consideration for Dermatologists, Cosmetologists, Aesthetic, and Plastic Surgeons

Cameron R. Moattari et al.

Summary: Hair loss disorders can cause distress to patients and have a significant impact on their quality of life. Individualized treatment approaches that address both medical and psychological aspects are necessary. This review discusses the effects of common hair loss disorders on quality of life and provides insights into psychological approaches for improving care. The integration of psychodermatology and psychotrichology in medical training programs is crucial.

SKIN APPENDAGE DISORDERS (2022)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Artificial Intelligence for Interstitial Lung Disease Analysis on Chest Computed Tomography: A Systematic Review

Shelly Soffer et al.

Summary: Artificial intelligence (AI) has the potential to contribute to the radiologic diagnosis and classification of interstitial lung disease (ILD) in high-resolution computed tomography (HRCT), but the accuracy performance is still not satisfactory, and research is limited by a small number of retrospective studies. Only well-designed prospective controlled studies can accurately assess the value of existing AI tools for ILD evaluation.

ACADEMIC RADIOLOGY (2022)

Add to Collection

Review Oncology

Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)- related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and management

Sandra M. Swain et al.

Summary: Trastuzumab deruxtecan is an antibody-drug conjugate that targets human epidermal growth factor receptor 2. Interstitial lung disease (ILD)/pneumonitis is a possible adverse event associated with T-DXd, which can range from low grade to fatal. Increasing understanding of T-DXd-related ILD/pneumonitis is crucial for improving patient outcomes. Accurate diagnosis of drug-related ILD/pneumonitis requires ruling out other potential causes. Early symptoms are challenging to identify due to their nonspecific nature, leading to delayed diagnosis.

CANCER TREATMENT REVIEWS (2022)

Add to Collection

Review Respiratory System

Drug-induced interstitial lung disease

Paolo Spagnolo et al.

Summary: Drug-induced interstitial lung disease (ILD) is increasingly common and can have various clinical manifestations. Early identification and discontinuation of the culprit drug are crucial for treatment. Mitigation strategies may be needed for certain drugs to prevent complications.

EUROPEAN RESPIRATORY JOURNAL (2022)

Add to Collection

Review Hematology

Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies

David J. Kuter

Summary: Chemotherapy-induced thrombocytopenia (CIT) is a common complication in the treatment of non-hematologic malignancies. Platelet growth factors can improve treatment outcomes and reduce the need for platelet transfusions in CIT.

HAEMATOLOGICA (2022)

Add to Collection

Article Oncology

Systemic Therapy for Advanced Human 3 Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline Update

Sharon H. Giordano et al.

Summary: The purpose of this study is to update guideline recommendations for systemic therapy in HER2-positive advanced breast cancer patients. Based on a systematic literature review, recommendations were made including the use of HER2-targeted therapy and evaluation on a case-by-case basis.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer

J. Cortes et al.

Summary: Among patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and a taxane, trastuzumab deruxtecan was associated with a lower risk of disease progression or death compared to trastuzumab emtansine. However, treatment with trastuzumab deruxtecan was associated with interstitial lung disease and pneumonitis.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Review Oncology

Clinical Practices and Institutional Protocols on Prophylaxis, Monitoring, and Management of Selected Adverse Events Associated with Trastuzumab Deruxtecan

Aditya Bardia et al.

Summary: This article reviews the management of adverse events associated with the administration of T-DXd, a new therapy for HER2-positive metastatic breast cancer. It provides practical insights and guidance for healthcare providers based on their experience with T-DXd. The article emphasizes the importance of preventing, monitoring, and managing treatment-related adverse events for successful implementation of T-DXd.

ONCOLOGIST (2022)

Add to Collection

Article Oncology

HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment

Federica Miglietta et al.

Summary: The expression of HER2-low-positive shows high instability from primary breast cancer to residual disease after neoadjuvant treatment. HER2-low-positive expression in residual disease may guide personalized adjuvant treatment for high-risk patients in clinical trials.

NPJ BREAST CANCER (2022)

Add to Collection

Review Oncology

Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment

P. Conte et al.

Summary: Drug-induced interstitial lung disease (DIILD) is a form of interstitial lung disease resulting from exposure to drugs causing inflammation and possibly interstitial fibrosis. Antineoplastic drugs are the primary cause of DIILD, but there are currently no specific guidelines on the diagnosis and treatment of DIILD caused by anticancer drugs.

ESMO OPEN (2022)

Add to Collection

Meeting Abstract Oncology

Trastuzumab deruxtecan vs T-DM1 in HER2+mBC in Asian subgroup: Results of the randomized phase 3 study DESTINY-Breast03

Seock-Ah Im et al.

ANNALS OF ONCOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

Shanu Modi et al.

Summary: Trastuzumab deruxtecan demonstrated significantly longer progression-free and overall survival compared to physician's choice chemotherapy in patients with HER2-low metastatic breast cancer.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Oncology

Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies

C. A. Powell et al.

Summary: This pooled analysis described the incidence of drug-related interstitial lung disease (ILD)/pneumonitis in patients treated with T-DXd. Most patients experienced low-grade events within the first 12 months of treatment. While the benefit-risk of T-DXd treatment is positive, some patients may be at increased risk of developing ILD/pneumonitis.

ESMO OPEN (2022)

Add to Collection

Review Oncology

Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer

H. S. Rugo et al.

Summary: This article discusses the management of common and special interest adverse events in patients with HER2-positive unresectable/metastatic breast cancer receiving T-DXd treatment. Prophylaxis for nausea and vomiting and proactive management of ILD/pneumonitis are highlighted as particularly important. Strategies for managing other T-DXd-related adverse events are also discussed.

ESMO OPEN (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)

Alexander R. Lyon et al.

EUROPEAN HEART JOURNAL (2022)

Add to Collection

Article Oncology

Disparities in Access to Systemic Treatment for Breast Cancer in Thailand and Major Asian Territories

Suthinee Ithimakin et al.

Summary: This study examined the disparities in access to breast cancer drugs in various Asian countries. The findings suggest that essential breast cancer drugs are generally accessible in most surveyed territories, but there is a discrepancy in accessing high-cost drugs in Thailand compared to other Asian territories.

JOURNAL OF BREAST CANCER (2022)

Add to Collection

Article Rheumatology

Assessing the diagnostic value of a potential screening tool for detecting early interstitial lung disease at the onset of inflammatory rheumatic diseases

Tobias Hoffmann et al.

Summary: This study aimed to evaluate the diagnostic value and utility of a stepwise approach as a potential ILD screening tool in patients with newly diagnosed IRD. The combination of reduced diffusing capacity for carbon monoxide (DLCO), chest X-ray, and pulmonary high-resolution computed tomography (HRCT) yielded the highest sensitivity and specificity in detecting ILD at the onset of IRD.

ARTHRITIS RESEARCH & THERAPY (2022)

Add to Collection

Review Respiratory System

International consensus on lung function testing during the COVID-19 pandemic and beyond

Aisling McGowan et al.

Summary: The COVID-19 pandemic has adversely affected respiratory diagnostic services worldwide. An international consensus statement by experts in the field of lung function and respiratory physiology presents strategies for the safe delivery of lung function testing services during and beyond the pandemic.

ERJ OPEN RESEARCH (2022)

Add to Collection

Article Respiratory System

Taxane-induced acute interstitial pneumonitis in patients with breast cancer and outcome of taxane rechallenge

T. M. Anoop et al.

Summary: This study aimed to investigate the occurrence of taxane-induced acute interstitial pneumonitis in breast cancer patients receiving chemotherapy and analyze the outcomes of taxane rechallenge in these patients. The results showed that after steroid treatment, most patients had complete resolution of lung abnormalities, while a small percentage still had residual interstitial lung disease. Taxane rechallenge was done in some patients with safety measures of short-course oral steroids, and no recurrence of pneumonitis or mortality was observed.

LUNG INDIA (2022)

Add to Collection

Article Oncology

Evaluation of potential complication of interstitial lung disease with abemaciclib and palbociclib treatments

Hideki Nawa et al.

Summary: This study evaluated the clinical incidence of interstitial lung disease caused by abemaciclib and palbociclib, two CDK4/6 inhibitors, and found that both drugs are associated with a potential complication of interstitial lung disease regardless of age. Signals of adverse events were detected in both the JADER and FAERS databases.

CANCER REPORTS (2022)

Add to Collection

Article Hematology

A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies

Hanny Al-Samkari et al.

Summary: This study retrospectively evaluated patients with chemotherapy-induced thrombocytopenia (CIT) treated with romiplostim at four US centers. The results demonstrated that romiplostim was safe and effective for most solid tumor patients.

HAEMATOLOGICA (2021)

Add to Collection

Article Medical Informatics

Bridging the Gap Between RCTs and RWE Through Endpoint Selection

Robert J. LoCasale et al.

Summary: This commentary discusses the value in bridging the industry disconnect between RTCs and RWE to promote the use of RWE in the RCT environment. It explores RCT endpoints along several axes including their clinical relevance and direct patient benefit, comparing them with their real-world counterparts to identify suitable paths or gaps for assimilating RWE endpoints into the RCT environment.

THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2021)

Add to Collection

Article Oncology

ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

A. Gennari et al.

ANNALS OF ONCOLOGY (2021)

Add to Collection

Article Oncology

Scalp cooling in breast cancer patients treated with docetaxel-cyclophosphamide: patient- and nurse-reported results

A. Coolbrandt et al.

Summary: Scalp cooling is successful in preventing severe chemotherapy-induced alopecia in almost half of the patients with breast cancer treated with docetaxel 75 mg/m(2)- cyclophosphamide 600 mg/m(2). Both patient- and nurse-reported data showed a variation in the efficacy of scalp cooling, with 55% of patients being (very) satisfied with the results.

BREAST CANCER RESEARCH AND TREATMENT (2021)

Add to Collection

Article Pharmacology & Pharmacy

Population Pharmacokinetics of Trastuzumab Deruxtecan in Patients With HER2-Positive Breast Cancer and Other Solid Tumors

Ophelia Yin et al.

Summary: This study characterized the pharmacokinetics of Trastuzumab deruxtecan in patients with HER2-positive breast cancer or other solid tumor malignancies. Results showed no significant differences in steady-state exposure of the drug in different patient populations, suggesting that dose adjustment based on specific patient characteristics is not necessary.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

Add to Collection

Article Oncology

Out-of-pocket medical expenses compared across five years for patients with one of five common cancers in Australia

Astrid J. Rodriguez-Acevedo et al.

Summary: Out-of-pocket expenses for cancer patients have significantly increased over time, especially for women with breast cancer and those without private health insurance. These cost increases resulted from both higher prices and higher volumes of health services, with variations by cancer type.

BMC CANCER (2021)

Add to Collection

Article Oncology

Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes

Aanika Balaji et al.

Summary: Steroid-refractory ICI-pneumonitis accounted for 18.5% of multidisciplinary irAE care referrals. This condition often occurred early in patients' treatment courses and most commonly presented with a diffuse alveolar damage (DAD) radiographic pattern. Patients treated with IVIG alone showed improvement in level-of-care and oxygenation requirements, with lower fatality rates (43%) compared to those treated with infliximab (100% mortality).

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Add to Collection

Article Medicine, General & Internal

Cardiac surveillance for anti HER2 chemotherapy

Patrick Collier et al.

Summary: Surveillance of left ventricular function for anti-HER2 chemotherapy, based on historical data involving anthracycline therapy, may not be necessary for patients without cardiovascular risk factors and not taking anthracyclines, as recent data suggests cardiotoxicity detected by screening is rare and usually benign. A more focused cardiac surveillance strategy is advocated to avoid the burden of repetitive echocardiography and the risk of false-positive results leading to discontinuation of lifesaving treatment.

CLEVELAND CLINIC JOURNAL OF MEDICINE (2021)

Add to Collection

Review Oncology

The Exciting New Field of HER2-Low Breast Cancer Treatment

Daniel Eiger et al.

Summary: The article discusses the expression of HER2 in breast cancer and the development of drugs targeting HER2. Patients with HER2-positive breast cancer have higher chances of cure and survival, and now there are also treatments available for patients with lower levels of HER2 expression.

CANCERS (2021)

Add to Collection

Meeting Abstract Oncology

Analysis of study drug-related interstitial lung disease (ILD) in patients (pts) with HER2+metastatic breast cancer (mBC) treated with trastuzumab deruxtecan (T-DXd)

C. A. Powell et al.

ANNALS OF ONCOLOGY (2021)

Add to Collection

Article Pharmacology & Pharmacy

Exposure-Response Relationships in Patients With HER2-Positive Metastatic Breast Cancer and Other Solid Tumors Treated With Trastuzumab Deruxtecan

Ophelia Yin et al.

Summary: Trastuzumab deruxtecan (T-DXd) has been approved for HER2-positive metastatic breast cancer and gastric cancer, with the 5.4 mg/kg every-3-weeks dosage justified based on exposure-efficacy analysis. Intact T-DXd area under the concentration-time curve was significantly associated with objective response rate, while no significant exposure-response relationships were observed for duration of response or progression-free survival. Higher exposure to T-DXd or released drug was correlated with increased adverse events, suggesting a dose-response relationship with higher ORR and toxicity at 6.4 mg/kg compared to 5.4 mg/kg.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

Add to Collection

Review Oncology

Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates A Review

Paolo Tarantino et al.

Summary: ERBB2-directed antibody-drug conjugates have revolutionized breast cancer treatment and shown promise in other tumors, but recent clinical observations have raised concerns about potential lung toxicity, highlighting the importance of appropriate diagnosis and management strategies.

JAMA ONCOLOGY (2021)

Add to Collection

Article Chemistry, Medicinal

Clinical Outcomes of Secondary Prophylactic Granulocyte Colony-Stimulating Factors in Breast Cancer Patients at a Risk of Neutropenia with Doxorubicin and Cyclophosphamide-Based Chemotherapy

Jae Hee Choi et al.

Summary: This retrospective study of 320 breast cancer patients who completed adjuvant AC-based chemotherapy found that secondary prophylaxis with G-CSF can reduce the risk of recurrent severe neutropenic events and improve clinical outcomes.

PHARMACEUTICALS (2021)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Preprocedural fasting for contrast-enhanced CT: when experience meets evidence

Heng Liu et al.

Summary: The review discusses the lack of methodologically acceptable evidence for traditional preparatory fasting policy prior to ICM-assisted CECT examinations. It highlights the potential harm of excessive fasting and emphasizes that preprocedural fasting is not recommended by the latest guidelines. The review also suggests that changes in the traditional preparatory fasting policy can have positive and significant implications on clinical practice.

INSIGHTS INTO IMAGING (2021)

Add to Collection

Article Multidisciplinary Sciences

Simple method for detecting idiopathic interstitial pneumonias by measuring vertical lung length on chest X-ray

Masato Karayama et al.

Summary: Measuring vertical lung length on chest X-rays can aid in the accurate detection of idiopathic interstitial pneumonias (IIPs), as the method has shown high diagnostic accuracy in both exploratory and validation cohorts.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Respiratory System

Interstitial Lung Disease in 2020: A History of Progress

Sabina A. Guler et al.

CLINICS IN CHEST MEDICINE (2021)

Add to Collection

Review Respiratory System

A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease

Christopher J. Ryerson et al.

Summary: This review discusses the evaluation and management of patients with unclassifiable ILD, emphasizing the importance of accurate ILD diagnosis and the potential impact of specific features on management decisions. It highlights the increasing role of antifibrotic medications in fibrotic ILDs, while underscoring the ongoing relevance of immunomodulatory therapies for many patient populations. The review provides a practical approach for clinicians and calls for additional research to support a rational and standardized management approach for patients with unclassifiable ILD.

EUROPEAN RESPIRATORY JOURNAL (2021)

Add to Collection

Article Gastroenterology & Hepatology

British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults

Jonathon Snook et al.

Summary: Iron deficiency anaemia is a major global cause of disease burden, diagnosed through blood testing and treated with iron replacement therapy. Causes include poor diet and gastrointestinal pathologies, with endoscopy and radiological scanning used for diagnosis and assessment in some cases.

GUT (2021)

Add to Collection

Review Medicine, General & Internal

Singapore's health-care system: key features, challenges, and shifts

Chorh Chuan Tan et al.

Summary: Since Singapore's independence in 1965, its healthcare system has emphasized personal responsibility and government intervention, with reforms implemented in 2012 to address challenges such as bed shortages and high out-of-pocket payments. However, more fundamental changes are needed to address the underlying drivers of system stress, as recognized by the Ministry of Health's "Three Beyonds" approach in 2016.

LANCET (2021)

Add to Collection

Editorial Material Oncology

HER2: a never ending story

Maria Vittoria Dieci et al.

LANCET ONCOLOGY (2021)

Add to Collection

Review Medicine, General & Internal

Efficacy of Qigong Exercise for Treatment of Fatigue: A Systematic Review and Meta-Analysis

Rui Wang et al.

Summary: This meta-analysis of 16 randomized controlled trials suggests that Qigong exercise may be beneficial for improving fatigue in patients diagnosed with various diseases. However, the improvement in quality of life was not significant. The results of subgroup analyses remained stable, but further studies are needed to better understand the benefits of Qigong exercise in primary medical care.

FRONTIERS IN MEDICINE (2021)

Add to Collection

Review Medicine, General & Internal

The Financial and Radiation Burden of Early Reimaging in Neurosurgical Patients: An Original Study and Review of the Literature

Rebecca Houston et al.

Summary: This paper reviews the patterns and motivations of repeat CT scans for transferred trauma patients, highlighting the significant impact of neurosurgeons in decision-making. Findings suggest that overuse of neuroimaging by non-trauma center practitioners and non-neurosurgical staff at trauma centers is mainly due to their lower comfort level with neuroradiology and fear of litigation. Education of non-neurosurgical staff is essential in preventing inappropriate neuroaxis imaging.

CUREUS JOURNAL OF MEDICAL SCIENCE (2021)

Add to Collection

Review Medicine, General & Internal

Pulmonary function testing for the early detection of drug-induced lung disease: a systematic review in adults treated with drugs associated with pulmonary toxicity

Allan Bui et al.

INTERNAL MEDICINE JOURNAL (2020)

Add to Collection

Article Medicine, General & Internal

Eribulin-induced Interstitial Pneumonia: A Case Series and Retrospective Cohort Study

Manabu Murakami et al.

INTERNAL MEDICINE (2020)

Add to Collection

Article Oncology

Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Hironobu Hashimoto et al.

LANCET ONCOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

Shanu Modi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Pharmacology & Pharmacy

Patient-Related Risk Factors for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review

Abu Saleh Mohammad Mosa et al.

FRONTIERS IN PHARMACOLOGY (2020)

Add to Collection

Article Critical Care Medicine

Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic

Andrew Kouri et al.

CHEST (2020)

Add to Collection

Article Oncology

Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment

A. Fabi et al.

ANNALS OF ONCOLOGY (2020)

Add to Collection

Review Hematology

How I treat cancer-associated anemia

Jeffrey A. Gilreath et al.

BLOOD (2020)

Add to Collection

Article Oncology

Antiemetics: ASCO Guideline Update

Paul J. Hesketh et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Article Oncology

Interstitial pneumonitis related to trastuzumab deruxtecan, a human epidermal growth factor receptor 2-targeting Ab-drug conjugate, in monkeys

Kazuyoshi Kumagai et al.

CANCER SCIENCE (2020)

Add to Collection

Article Education, Scientific Disciplines

Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and cyclophosphamide in nonmalignant hematologic diseases

Luis Malpica et al.

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2020)

Add to Collection

Article Health Care Sciences & Services

Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations

Amelia J. Averitt et al.

NPJ DIGITAL MEDICINE (2020)

Add to Collection

Article Oncology

Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for managing highly emetogenic chemotherapy in Southeast Asia: a multinational study

Suthan Chanthawong et al.

SUPPORTIVE CARE IN CANCER (2019)

Add to Collection

Review Cardiac & Cardiovascular Systems

Cardiotoxicity of HER2-targeted therapies

Robert S. Copeland-Halperin et al.

CURRENT OPINION IN CARDIOLOGY (2019)

Add to Collection

Article Oncology

Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update

Julia Bohlius et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

Add to Collection

Article Oncology

Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study

Kenji Tamura et al.

LANCET ONCOLOGY (2019)

Add to Collection

Article Oncology

Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus Exemestane

Annelieke E. C. A. B. Willemsen et al.

TARGETED ONCOLOGY (2019)

Add to Collection

Review Oncology

Breast Cancer: Reimbursement Policies and Adoption of New Therapeutic Agents by National Health Systems

Dario Trapani et al.

BREAST CARE (2019)

Add to Collection

Article Oncology

Effects of progressive muscle relaxation and mindfulness meditation on fatigue, coping styles, and quality of life in early breast cancer patients: An assessor blinded, three-arm, randomized controlled trial

Zehra Gok Metin et al.

EUROPEAN JOURNAL OF ONCOLOGY NURSING (2019)

Add to Collection

Article Pharmacology & Pharmacy

From Clinical Trial Efficacy to Real-Life Effectiveness: Why Conventional Metrics do not Work

Jean-Pierre Boissel et al.

DRUGS-REAL WORLD OUTCOMES (2019)

Add to Collection

Article Respiratory System

The characterisation of interstitial lung disease multidisciplinary team meetings: a global study

Luca Richeldi et al.

ERJ OPEN RESEARCH (2019)

Add to Collection

Letter Respiratory System

Cyclophosphamide in steroid refractory unclassifiable idiopathic interstitial pneumonia and interstitial pneumonia with autoimmune features (IPAF)

Ivo A. Wiertz et al.

EUROPEAN RESPIRATORY JOURNAL (2018)

Add to Collection

Article Medicine, General & Internal

Real-world Evidence versus Randomized Controlled Trial: Clinical Research Based on Electronic Medica Records

Hun-Sung Kim et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2018)

Add to Collection

Article Oncology

Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting-introduction

Matti Aapro

SUPPORTIVE CARE IN CANCER (2018)

Add to Collection

Article Oncology

Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary

Charles A. Schiffer et al.

JOURNAL OF ONCOLOGY PRACTICE (2018)

Add to Collection

Article Critical Care Medicine

Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Add to Collection

Article Multidisciplinary Sciences

Health services costs for cancer care in Australia: Estimates from the 45 and Up Study

David E. Goldsbury et al.

PLOS ONE (2018)

Add to Collection

Article Nursing

The Relationship between Perception of Social Support and Fatigue in Patients with Cancer

Leila Mardanian-Dehkordi et al.

IRANIAN JOURNAL OF NURSING AND MIDWIFERY RESEARCH (2018)

Add to Collection

Article Oncology

Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines

M. Aapro et al.

ANNALS OF ONCOLOGY (2018)

Add to Collection

Review Respiratory System

Role of imaging in progressive-fibrosing interstitial lung diseases

Simon L. F. Walsh et al.

EUROPEAN RESPIRATORY REVIEW (2018)

Add to Collection

Article Respiratory System

Integrated Use of Lung Ultrasound and Chest X-Ray in the Detection of Interstitial Lung Disease

Luca Vizioli et al.

RESPIRATION (2017)

Add to Collection

Article Hematology

Eltrombopag for thrombocytopenia in patients with advanced solid tumors receiving gemcitabine-based chemotherapy: a randomized, placebo-controlled phase 2 study

Eric S. Winer et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)

Add to Collection

Article Oncology

Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study

Toshihiko Doi et al.

LANCET ONCOLOGY (2017)

Add to Collection

Article Medicine, General & Internal

Anemia Evaluation and Diagnostic Tests

Michael J. Cascio et al.

MEDICAL CLINICS OF NORTH AMERICA (2017)

Add to Collection

Review Pharmacology & Pharmacy

Delayed Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Incidence, and Current Management

Bernardo L. Rapoport

FRONTIERS IN PHARMACOLOGY (2017)

Add to Collection

Review Respiratory System

Interstitial lung disease: the diagnostic role of bronchoscopy

Jad Kebbe et al.

JOURNAL OF THORACIC DISEASE (2017)

Add to Collection

Article Respiratory System

Serum KL-6 and surfactant protein-D as monitoring and predictive markers of interstitial lung disease in patients with systemic sclerosis and mixed connective tissue disease

Hideaki Yamakawa et al.

JOURNAL OF THORACIC DISEASE (2017)

Add to Collection

Review Integrative & Complementary Medicine

Cancer and Cancer-Related Fatigue and the Interrelationships With Depression, Stress, and Inflammation

Daniel Weber et al.

JOURNAL OF EVIDENCE-BASED INTEGRATIVE MEDICINE (2017)

Add to Collection

Article Medicine, General & Internal

Update in diagnosis and management of interstitial lung disease

Theresia A. Mikolasch et al.

CLINICAL MEDICINE (2017)

Add to Collection

Article Public, Environmental & Occupational Health

Cancer mortality-to-incidence ratio as an indicator of cancer management outcomes in Organization for Economic Cooperation and Development countries

Eunji Choi et al.

EPIDEMIOLOGY AND HEALTH (2017)

Add to Collection

Article Oncology

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines

J. Klastersky et al.

ANNALS OF ONCOLOGY (2016)

Add to Collection

Article Oncology

DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1

Yusuke Ogitani et al.

CLINICAL CANCER RESEARCH (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

Jose Luis Zamorano et al.

EUROPEAN HEART JOURNAL (2016)

Add to Collection

Article Health Care Sciences & Services

Tai Chi Exercise for Cancer-Related Fatigue in Patients With Lung Cancer Undergoing Chemotherapy: A Randomized Controlled Trial

Li-Li Zhang et al.

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2016)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Computed tomography and patient risk: Facts, perceptions and uncertainties

Stephen P. Power et al.

WORLD JOURNAL OF RADIOLOGY (2016)

Add to Collection

Review Oncology

Current Status and Future Projections of Breast Cancer in Asia

Lei Fan et al.

BREAST CARE (2015)

Add to Collection

Article Oncology

Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update

Thomas J. Smith et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Add to Collection

Article Area Studies

Comparing the Health Care Systems of High-Performing Asian Countries

Amanda Smullen et al.

ASIA & THE PACIFIC POLICY STUDIES (2015)

Add to Collection

Article Respiratory System

An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease

Anne E. Holland et al.

EUROPEAN RESPIRATORY JOURNAL (2014)

Add to Collection

Review Oncology

Cancer-related fatigue-mechanisms, risk factors, and treatments

Julienne E. Bower

NATURE REVIEWS CLINICAL ONCOLOGY (2014)

Add to Collection

Review Respiratory System

Consensus statement for the diagnosis and treatment of drug-induced lung injuries

Keishi Kubo et al.

RESPIRATORY INVESTIGATION (2013)

Add to Collection

Article Critical Care Medicine

An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease

Keith C. Meyer et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)

Add to Collection

Article Oncology

Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines

G. Curigliano et al.

ANNALS OF ONCOLOGY (2012)

Add to Collection

Article Oncology

Perception, Attitudes, Preparedness and Experience of Chemotherapy-Induced Alopecia among Breast Cancer Patients: a Qualitative Study

Im-Ryung Kim et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)

Add to Collection

Article Medicine, General & Internal

Cancer-Related Fatigue Epidemiology, Pathogenesis, Diagnosis, and Treatment

Markus Horneber et al.

DEUTSCHES ARZTEBLATT INTERNATIONAL (2012)

Add to Collection

Review Oncology

Treatment of HER2-positive breast cancer: current status and future perspectives

Carlos L. Arteaga et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2012)

Add to Collection

Article Gastroenterology & Hepatology

CMV reactivation caused by methylprednisolone therapy for ARDS after esophagectomy

Yusuke Sato et al.

ESOPHAGUS (2012)

Add to Collection

Review Medicine, General & Internal

Radiation Risk From Medical Imaging

Eugene C. Lin

MAYO CLINIC PROCEEDINGS (2010)

Add to Collection

Review Oncology

Cancer Pharmacoethnicity: Ethnic Differences in Susceptibility to the Effects of Chemotherapy

Peter H. O'Donnell et al.

CLINICAL CANCER RESEARCH (2009)

Add to Collection

Review Oncology

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours

M. S. Aapro et al.

EUROPEAN JOURNAL OF CANCER (2006)

Add to Collection

Article Respiratory System

General considerations for lung function testing

MR Miller et al.

EUROPEAN RESPIRATORY JOURNAL (2005)

Add to Collection

Article Critical Care Medicine

Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis

H Takahashi et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.